Related Experiment Video
Updated: May 28, 2026
09:03
Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
Published on: March 10, 2020
Prostanoid receptor assays
J Chen1, D F Woodward, R A Coleman
1Allergan, Irvine, California, USA.
Current Protocols in Pharmacology
|October 1, 2011
Summary
This study reviews prostanoid receptors, including prostaglandins (PGs) and thromboxanes (TXs), and their subtypes like EP receptors. It highlights available assays for studying these receptors in smooth muscle and platelets.
Area of Science:
- Biochemistry
- Pharmacology
Background:
- Prostanoids, encompassing prostaglandins (PGs) and thromboxanes (TXs), are key signaling molecules.
- These molecules exert their effects by binding to specific G-protein coupled receptors (GPCRs).
- Five distinct prostanoid receptor types (DP, EP, FP, IP, TP) are known, each sensitive to a specific natural prostanoid.
Purpose of the Study:
- To detail the characteristics of prostanoid receptors and their subtypes.
- To focus on the EP receptor family, which has four well-characterized subtypes (EP₁, EP₂, EP₃, EP₄).
- To present available assays for studying prostanoid receptors in smooth muscle and platelet preparations.
Main Methods:
- Review of existing literature on prostanoid receptor families and subtypes.
- Description of receptor expression patterns in mammalian tissues.
- Compilation of functional assays for prostanoid receptor research.
Main Results:
- Prostanoid receptors (DP, EP, FP, IP, TP) are widely distributed in mammals.
- EP receptor subtypes (EP₁, EP₂, EP₃, EP₄) are highly expressed in smooth muscle and platelets.
- Various assays are available for studying these receptors, despite challenges with isolated preparations.
Conclusions:
- Prostanoid receptors and their subtypes play significant roles in physiological processes.
- The EP receptor family, particularly its subtypes, is a key area of research.
- Established assays facilitate the investigation of prostanoid receptor function in relevant biological systems.
Related Concept Videos
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...